Home › Asset managers › ProShares › 2024-2025 › Against the board
2,735 proposals in the 2024-2025 proxy season: ProShares voted against, or withheld its votes from, 2,693 proposals put forward by company boards, and voted for 42 shareholder proposals, by its own Form N-PX filings.
Two kinds of vote are listed: a board-sponsored proposal ProShares voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,735 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | ProShares voted | Funds |
|---|---|---|---|---|---|---|---|
| Lamar Advertising Company | May 15, 2025 | Election of directors: Kevin P. Reilly, Jr. | Director Elections | Board | WITHHOLD | 9 | |
| Lamar Advertising Company | May 15, 2025 | Election of directors: Stephen P. Mumblow | Director Elections | Board | WITHHOLD | 9 | |
| Lamar Advertising Company | May 15, 2025 | Election of directors: Thomas V. Reifenheiser | Director Elections | Board | WITHHOLD | 9 | |
| Lamar Advertising Company | May 15, 2025 | Election of directors: Wendell Reilly | Director Elections | Board | WITHHOLD | 9 | |
| Larimar Therapeutics, Inc. | May 13, 2025 | Election of Class II Director for a Three-Year Term Expiring in 2028: Thomas E. Hamilton | Director Elections | Board | WITHHOLD | 9 | |
| Lexeo Therapeutics, Inc. | June 26, 2025 | The election of Steven Altschuler and Reinaldo Diaz as Class II directors: Reinaldo Diaz | Director Elections | Board | WITHHOLD | 9 | |
| Lexeo Therapeutics, Inc. | June 26, 2025 | The election of Steven Altschuler and Reinaldo Diaz as Class II directors: Steven Altschuler | Director Elections | Board | WITHHOLD | 9 | |
| Lexicon Pharmaceuticals, Inc. | June 2, 2025 | Ratification and approval of the amendment to the Company's 2017 Equity Incentive Plan | Compensation | Board | AGAINST | 9 | |
| Lightwave Logic, Inc. | May 15, 2025 | Election of Directors: Craig Ciesla | Director Elections | Board | WITHHOLD | 9 | |
| Lyell Immunopharma, Inc. | May 15, 2025 | Election of Class I Director: Catherine Friedman | Director Elections | Board | WITHHOLD | 9 | |
| MacroGenics, Inc. | May 21, 2025 | To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. | Compensation | Board | AGAINST | 9 | |
| Maplebear Inc. | May 22, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 9 | |
| Maplebear Inc. | May 22, 2025 | To elect the following Class II director nominees: Ravi Gupta | Director Elections | Board | WITHHOLD | 9 | |
| MaxCyte, Inc. | June 18, 2025 | To elect the Board's three nominees as identified in the accompanying Proxy Statement as Class I directors: Maher Masoud | Director Elections | Board | WITHHOLD | 9 | |
| Medpace Holdings, Inc. | May 16, 2025 | Election of Directors: August J. Troendle | Director Elections | Board | WITHHOLD | 9 | |
| MeiraGTx Holdings Plc | June 12, 2025 | Election of Director: Thomas E. Shenk, Ph.D. | Director Elections | Board | WITHHOLD | 9 | |
| MeiraGTx Holdings Plc | June 12, 2025 | To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. | Audit-related | Board | AGAINST | 9 | |
| MercadoLibre, Inc. | June 17, 2025 | Election of Directors: Class I Nominee: Stelleo Passos Tolda | Director Elections | Board | WITHHOLD | 9 | |
| MicroStrategy Incorporated | January 21, 2025 | To approve and adopt an amendment to Article Four of the MicroStrategy Incorporated Second Restated Certificate of Incorporation to increase the number of authorized shares of class A common stock, par value $0.001 per share, from 330,000,000 shares to 10,330,000,000 shares ("Proposal 1"). | Capital Structure | Board | AGAINST | 9 | |
| MicroStrategy Incorporated | January 21, 2025 | To approve and adopt an amendment to the MicroStrategy Incorporated 2023 Equity Incentive Plan to provide for automatic equity award grants to new directors upon their appointment to the Board of Directors ("Proposal 3"). | Compensation | Board | AGAINST | 9 | |
| MicroStrategy Incorporated | June 12, 2025 | To elect the following eight (8) directors for the next year: Carl J. Rickertsen | Director Elections | Board | WITHHOLD | 9 | |
| MicroStrategy Incorporated | June 12, 2025 | To elect the following eight (8) directors for the next year: Jarrod M. Patten | Director Elections | Board | WITHHOLD | 9 | |
| MicroStrategy Incorporated | June 12, 2025 | To elect the following eight (8) directors for the next year: Michael J. Saylor | Director Elections | Board | WITHHOLD | 9 | |
| MicroStrategy Incorporated | June 12, 2025 | To elect the following eight (8) directors for the next year: Phong Q. Le | Director Elections | Board | WITHHOLD | 9 | |
| MicroStrategy Incorporated | June 12, 2025 | To elect the following eight (8) directors for the next year: Stephen X. Graham | Director Elections | Board | WITHHOLD | 9 | |
| MicroVision, Inc. | June 6, 2025 | To approve an amendment to the 2022 MicroVision, Inc. Equity Incentive Plan. | Compensation | Board | AGAINST | 9 | |
| MicroVision, Inc. | June 6, 2025 | To approve on a non-binding advisory basis the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 9 | |
| Mineralys Therapeutics, Inc. | May 22, 2025 | Election of Class II directors for a three-year term to expire at the 2028 annual meeting of stockholders: Glenn P. Sblendorio | Director Elections | Board | WITHHOLD | 9 | |
| MoneyLion Inc. | April 10, 2025 | to adopt the Agreement and Plan of Merger, dated as of December 10, 2024 (such agreement, as it may be amended from time to time, is referred to as the "merger agreement"), by and among MoneyLion Inc. (referred to as "MoneyLion"), Gen Digital Inc. (referred to as "Gen Digital") and Maverick Group Holdings, Inc., a wholly-owned subsidiary of Gen Digital (referred to as "Merger Sub"), pursuant to which Merger Sub will be merged with and into MoneyLion (referred to as the "merger"), with MoneyLion surviving the merger as a wholly-owned subsidiary of Gen Digital (referred to as the "merger agreement proposal"); | Extraordinary Transactions | Board | AGAINST | 9 | |
| Nabors Industries Ltd. | June 3, 2025 | Approval, on a non-binding, advisory basis, of the compensation paid by the Company to its named executive officers. | Say-on-Pay | Board | AGAINST | 9 | |
| Nabors Industries Ltd. | June 3, 2025 | ELECTION OF DIRECTORS: Anthony R. Chase | Director Elections | Board | WITHHOLD | 9 | |
| Nabors Industries Ltd. | June 3, 2025 | ELECTION OF DIRECTORS: John P. Kotts | Director Elections | Board | WITHHOLD | 9 | |
| Nabors Industries Ltd. | June 3, 2025 | ELECTION OF DIRECTORS: Tanya S. Beder | Director Elections | Board | WITHHOLD | 9 | |
| Neumora Therapeutics, Inc. | May 28, 2025 | To approve the repricing of certain stock options outstanding under the 2023 Incentive Award Plan and the 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 9 | |
| Neumora Therapeutics, Inc. | May 28, 2025 | To elect two Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Alaa Halawa | Director Elections | Board | WITHHOLD | 9 | |
| Olema Pharmaceuticals, Inc. | June 10, 2025 | Election of the three nominees for Class II director named in the accompanying proxy statement to hold office until the Company's 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Cynthia Butitta | Director Elections | Board | WITHHOLD | 9 | |
| Ouster, Inc. | June 18, 2025 | Election of Class I Directors: Ernest E. Maddock | Director Elections | Board | WITHHOLD | 9 | |
| Pacific Biosciences of California, Inc. | June 4, 2025 | To approve the amendment of our 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 9 | |
| Pacific Biosciences of California, Inc. | June 4, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 9 | |
| Pliant Therapeutics, Inc. | June 5, 2025 | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. | Say-on-Pay | Board | AGAINST | 9 | |
| Precigen, Inc. | June 26, 2025 | Company Proposal - Approval, in compliance with Nasdaq Listing Rule 5635(c), of the additional issuance of shares of Series A Preferred Stock and Warrants to Randal J. Kirk as PIK dividends, in order for Mr. Kirk to receive PIK dividends on the Series A Preferred Stock on the same terms as the other investors. | Capital Structure | Board | AGAINST | 9 | |
| Precigen, Inc. | June 26, 2025 | Company Proposal - Election of Directors: Cesar Alvarez | Director Elections | Board | AGAINST | 9 | |
| Prime Medicine, Inc. | June 4, 2025 | To elect Thomas Cahill, M.D., Ph.D. and Robert Nelsen as Class III Directors: Robert Nelsen | Director Elections | Board | WITHHOLD | 9 | |
| Prime Medicine, Inc. | June 4, 2025 | To elect Thomas Cahill, M.D., Ph.D. and Robert Nelsen as Class III Directors: Thomas Cahill, M.D., Ph.D. | Director Elections | Board | WITHHOLD | 9 | |
| Pure Storage, Inc. | June 11, 2025 | An advisory vote on our named executive officer compensation. | Say-on-Pay | Board | AGAINST | 9 | |
| Pure Storage, Inc. | June 11, 2025 | Election of four Class I directors to serve until our Annual Meeting of Stockholders in 2028: Scott Dietzen | Director Elections | Board | WITHHOLD | 9 | |
| Pyxis Oncology, Inc. | June 18, 2025 | The election of Class I directors named in the proxy statement: Darren Cline | Director Elections | Board | WITHHOLD | 9 | |
| Pyxis Oncology, Inc. | June 18, 2025 | The election of Class I directors named in the proxy statement: Rachel Humphrey, M.D. | Director Elections | Board | WITHHOLD | 9 | |
| Pyxis Oncology, Inc. | June 18, 2025 | The election of Class I directors named in the proxy statement: Santhosh Palani, Ph.D., CFA | Director Elections | Board | WITHHOLD | 9 | |
| REGENXBIO Inc. | May 30, 2025 | Election of Four Class I Directors: Alexandra Glucksmann, Ph.D. | Director Elections | Board | WITHHOLD | 9 | |
| REGENXBIO Inc. | May 30, 2025 | Election of Four Class I Directors: Allan M. Fox | Director Elections | Board | WITHHOLD | 9 | |
| REGENXBIO Inc. | May 30, 2025 | Election of Four Class I Directors: Jennifer Zachary | Director Elections | Board | WITHHOLD | 9 | |
| REGENXBIO Inc. | May 30, 2025 | To approve the REGENXBIO Inc. 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 9 | |
| Riot Platforms, Inc. | June 10, 2025 | Approval, on a non-binding an advisory basis, of the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | AGAINST | 9 | |
| Shoals Technologies Group, Inc. | May 1, 2025 | Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers (i.e., "say-on-pay proposal). | Say-on-Pay | Board | AGAINST | 9 | |
| Shoals Technologies Group, Inc. | May 1, 2025 | Election of Class I Director Nominees: Toni Volpe | Director Elections | Board | WITHHOLD | 9 | |
| Shoals Technologies Group, Inc. | May 1, 2025 | Election of Class I Director Nominees: Ty Daul | Director Elections | Board | WITHHOLD | 9 | |
| Skywater Technology, Inc. | May 21, 2025 | Election of Directors: Loren A. Unterseher | Director Elections | Board | WITHHOLD | 9 | |
| Solaris Energy Infrastructure, Inc. | May 15, 2025 | Election of Directors: Cynthia M. Durrett | Director Elections | Board | WITHHOLD | 9 | |
| Solaris Energy Infrastructure, Inc. | May 15, 2025 | Election of Directors: Ray N. Walker, Jr. | Director Elections | Board | WITHHOLD | 9 | |
| Solaris Energy Infrastructure, Inc. | May 15, 2025 | Election of Directors: W. Howard Keenan, Jr. | Director Elections | Board | WITHHOLD | 9 | |
| Sonoco Products Company | April 16, 2025 | Advisory (non-binding) shareholder proposal regarding transparency in political spending. | Other Social Issues | Shareholder | Against | FOR | 9 |
| Sutro Biopharma, Inc. | June 6, 2025 | Election of Class I Directors: Heidi Hunter | Director Elections | Board | WITHHOLD | 9 | |
| Sutro Biopharma, Inc. | June 6, 2025 | Election of Class I Directors: Jon Wigginton, M.D. | Director Elections | Board | WITHHOLD | 9 | |
| Sutro Biopharma, Inc. | June 6, 2025 | Election of Class I Directors: Michael Dybbs, Ph.D. | Director Elections | Board | WITHHOLD | 9 | |
| TScan Therapeutics, Inc. | June 30, 2025 | To elect three Class I directors to the Company's Board of Directors: Garry Nicholson | Director Elections | Board | WITHHOLD | 9 | |
| Tango Therapeutics, Inc. | June 5, 2025 | Election of Class I Director: Lesley Ann Calhoun | Director Elections | Board | WITHHOLD | 9 | |
| Taysha Gene Therapies, Inc. | June 2, 2025 | To elect the Board's Class II Director nominees, Phillip B. Donenberg, CPA and Sukumar Nagendran, MD to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Phillip B. Donenberg, CPA | Director Elections | Board | WITHHOLD | 9 | |
| Tenable Holdings, Inc. | May 14, 2025 | To elect the Board of Directors' nominees Linda Zecher Higgins and Niloofar Razi Howe, to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Linda Zecher Higgins | Director Elections | Board | WITHHOLD | 9 | |
| Terns Pharmaceuticals, Inc. | June 11, 2025 | Election of Class I Directors for a three-year term: Hongbo Lu | Director Elections | Board | WITHHOLD | 9 | |
| The Carlyle Group Inc. | May 29, 2025 | Non-Binding Vote to Approve Named Executive Officer Compensation ("Say-on-Pay") | Say-on-Pay | Board | AGAINST | 9 | |
| The Trade Desk, Inc. | May 27, 2025 | The approval of The Trade Desk, Inc. 2025 Incentive Award Plan, which is an amendment and restatement of our 2016 Incentive Award Plan. | Compensation | Board | AGAINST | 9 | |
| Third Harmonic Bio, Inc. | June 5, 2025 | Election of Class III Directors: Geoff McDonough, M.D. | Director Elections | Board | WITHHOLD | 9 | |
| Third Harmonic Bio, Inc. | June 5, 2025 | Election of Class III Directors: Thomas M. Soloway | Director Elections | Board | WITHHOLD | 9 | |
| Voyager Therapeutics, Inc. | June 3, 2025 | To approve the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan. | Compensation | Board | AGAINST | 9 | |
| Weave Communications, Inc. | May 21, 2025 | Election of Directors: David Silverman | Director Elections | Board | WITHHOLD | 9 | |
| Weave Communications, Inc. | May 21, 2025 | Election of Directors: Tyler Newton | Director Elections | Board | WITHHOLD | 9 | |
| Westlake Corporation | May 8, 2025 | Election of Class III Directors: Albert Y. Chao | Director Elections | Board | WITHHOLD | 9 | |
| Westlake Corporation | May 8, 2025 | Election of Class III Directors: Carolyn C. Sabat | Director Elections | Board | WITHHOLD | 9 | |
| Westlake Corporation | May 8, 2025 | Election of Class III Directors: David T. Chao | Director Elections | Board | WITHHOLD | 9 | |
| Workiva Inc. | May 29, 2025 | Election of Directors: Martin J. Vanderploeg, Ph.D. | Director Elections | Board | WITHHOLD | 9 | |
| Workiva Inc. | May 29, 2025 | Election of Directors: Suku Radia | Director Elections | Board | WITHHOLD | 9 | |
| YETI Holdings, Inc. | May 1, 2025 | Election of three Class I directors: Elizabeth L. Axelrod | Director Elections | Board | WITHHOLD | 9 | |
| ZoomInfo Technologies Inc. | May 14, 2025 | To elect the director nominees listed in the Proxy Statement: Alison Gleeson | Director Elections | Board | WITHHOLD | 9 | |
| Zymeworks Inc. | December 10, 2024 | Election of Directors: Kelvin Neu | Director Elections | Board | WITHHOLD | 9 | |
| Zymeworks Inc. | December 10, 2024 | Election of Directors: Kenneth Galbraith | Director Elections | Board | WITHHOLD | 9 | |
| Zymeworks Inc. | December 10, 2024 | Election of Directors: Susan Mahony | Director Elections | Board | WITHHOLD | 9 | |
| fuboTV Inc. | June 17, 2025 | Approval of an amendment to the Company's 2020 Equity Incentive Plan to, among other things, increase the number of shares of Common Stock available for issuance; and | Compensation | Board | AGAINST | 9 | |
| nLIGHT, Inc. | June 10, 2025 | Election of Class I Directors: Camille Nichols | Director Elections | Board | WITHHOLD | 9 | |
| nLIGHT, Inc. | June 10, 2025 | Election of Class I Directors: Scott Keeney | Director Elections | Board | WITHHOLD | 9 | |
| scPharmaceuticals Inc. | June 3, 2025 | Election of Class II Directors: Mette Kirstine Agger | Director Elections | Board | WITHHOLD | 9 | |
| scPharmaceuticals Inc. | June 3, 2025 | Election of Class II Directors: William T. Abraham, M.D. | Director Elections | Board | WITHHOLD | 9 | |
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: Celia R. Brown | Director Elections | Board | WITHHOLD | 8 | |
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: Christina Shim | Director Elections | Board | WITHHOLD | 8 | |
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: Christopher G. McCann | Director Elections | Board | WITHHOLD | 8 | |
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: James F. McCann | Director Elections | Board | WITHHOLD | 8 | |
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: Larry Zarin | Director Elections | Board | WITHHOLD | 8 | |
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: Leonard J. Elmore | Director Elections | Board | WITHHOLD | 8 | |
| 1-800-FLOWERS.COM, Inc. | December 11, 2024 | Election of Directors: Stephanie Redish Hofmann | Director Elections | Board | WITHHOLD | 8 | |
| 1st Source Corporation | April 24, 2025 | Election of Directors for terms expiring April 2028: Daniel B. Fitzpatrick | Director Elections | Board | AGAINST | 8 |
← Previous Page 8 of 28 Next →
← Back to ProShares 2024-2025 overview
Built November 7, 2026 from SEC Form N-PX filings.